Cell easy
Cell easy
  • CDMO Services
    • Tissue & Cell Sourcing
    • Process and Analytical Development
    • Manufacturing
    • Analytics testing
    • Regulatory Support
  • Accelerator Platforms
    • CellAnalytics Platform
    • CellProcess Platform
    • MSC4All Platforms
  • About Us
  • Careers
  • News
Cell easy
  • CDMO Services
    • Tissue & Cell Sourcing
    • Process and Analytical Development
    • Manufacturing
    • Analytics testing
    • Regulatory Support
  • Accelerator Platforms
    • CellAnalytics Platform
    • CellProcess Platform
    • MSC4All Platforms
  • About Us
  • Careers
  • News

Daily: September 28, 2022

Home2022September28
By Guillaume LaySeptember 28, 2022

EMERCell & Cell-Easy sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001

TOULOUSE, France & MONTPELLIER, France _ September 22, 2022 Emercell has selected Cell-Easy as a long-term CDMO partner for the scale-up and manufacturing operations of its allogeneic NK cell-based product, with the objective to enter clinical phase in 2023. Emercell has signed a strategic agreement with Cell-Easy specialized in the

+ Read More

Brochure

  • Brochure.doc80kb
  • Brochure.pdf80kb

Gallery

Social icon

Let’s Work Together!

+Contact Us
  • Tel : +33 534 276 550
  • Adresse : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France

  • Legal Notice
  • Privacy Policy
  • LinkedIn